• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·VNDA
Held by 2 Gurus
Share

Vanda Pharmaceuticals Inc. Stocks

$ 4.15Last Updated 11.11.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 246.72M

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%

Trending

13.11.2026 11:08

"No One Is Irreplaceable": What Major Investors Are Saying About Nvidia Without Huang

13.11.2026 09:00

Nvidia has promised to invest $10 billion in Anthropic. Will Huang's departure derail the record-breaking IPO?

13.11.2026 08:00

Burry Increased His Bets Against the Nasdaq 100 and Chipmakers Following the Resignation of Nvidia's CEO

13.11.2026 03:33

Shares of Nvidia's competitor soared 16% on the back of strong revenue. Is it too late to buy?

13.11.2026 02:42

"A Golden Opportunity": Who Came Out Ahead on the Day Stocks Plummeted Following Huang's Resignation

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026